Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine.
R J
RJ
De Boer
C A
CA
Boucher
A S
AS
Perelson
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000821:virology*; D002648:Child; D002986:Clinical Trials as Topic; D016049:Didanosine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008954:Models, Biological
D019380:Anti-HIV Agents; D007166:Immunosuppressive Agents; D016049:Didanosine; D006918:Hydroxyurea